Genomic era diagnosis and management of hereditary and sporadic colon cancer
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 5 (5) , 1036-1047
Abstract
Genomic era diagnosis and management of hereditary and sporadic colon cancerKeywords
This publication has 103 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Adenine DNA glycosylase activity of 14 Human MutY homolog (MUTYH) variant proteins found in patients with colorectal polyposis and cancerHuman Mutation, 2010
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- Hereditary and Familial Colon CancerGastroenterology, 2010
- A Two-Step Model for Colon Adenoma Initiation and Progression Caused by APC LossCell, 2009
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancerNature Chemical Biology, 2009
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerNew England Journal of Medicine, 2008
- The Tumor Suppressor PP2A Aβ Regulates the RalA GTPaseCell, 2007
- A vision for the future of genomics researchNature, 2003